chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After 1st shot soar arm a few days  swollen knot several days and rash. 2nd shot soar arm ,  knot , still have rash from 1st shot not a color but can feel it . And 3 days after 2nd shot also had chest pains on and off a couple of days . Then no more pains  but still have rash on arm  . shots were 4/121/21 and 5/12/21  Since all this in July started feeling sick to stomach headaches everyday then July 31st woke up paralysis on left side of face Bells Palsy was diagnosed at ER  .
AFTER FLUZONE HD VACCINATION, PT DEVELOPED ARM PAIN.  HER PAIN WAS PROGRESSED TO ENTIRE LEFT ARM AND SHOULDER.  PT COULDN'T SLEEP WELL.  9/27/22 MORNING PT CALLED AND CAME IN TO SHOW ME.  HER ARM WAS TENDER TO TOUGH.  INJECTION AREA IS CLEAR.  NO SIGNS OF INFECTION.  INJECTION SITE WAS AT DELTOID MUSCLE AND NOT TOO HIGH TO CLOSE TO SHOULDER.  RECOMMENDED PT TO USE ICE PACK TO ICE IT LOCALLY.  ALSO GAVE PT OTC ACETAMINOPHEN FOR COMFORT.  9/28/22 I CALLED AND CHECKED WITH PT.  PT SAID SHE FELT MUCH BETTER.  SHE STILL FELT IT THOUGH.  I SAW PT ON 9/29/22.  SHE WAS OK..
TDaP was vaccinated on 8/17/18. On Monday, 8/20/18, employee claimed that (L) deltoid had become very sore on 8/18/18. Today (8/20/18), arm is reddened, mild edema noted. On 8/21/18, Dr evaluated arm as redness, warmth and edema was noted. He recommended OTC ibuprofen and cool packs. On 8/21/18 - she was referred to MD. If no better have MD evaluate on 8/22/18.
Metallic taste in mouth that subsided the next morning. Sore arm for 3 days Slightly feverish on and off for the first 2 days All of the above were relatively mild
PMH COPD not on supplemental oxygen therapy, CPAP, HTN, DMII, former tobacco abuse  presented to the ED  with SOA. Symptoms began 3/26 after 2nd COVID vaccine. No fever, chills, CP, palpitations. Patient was hospitalized here in the fall with acute resp failure due to COVID, and developed PE for which he was on eliquis until recently
Vaccine administered 1/16 in left deltoid- low grade temperature to 99.5, malaise, fatigue, dizziness, arm pain 7 hours post administration. 1/17- large axillary lymphadenopathy with continued fatigue 1/18- fatigue 1/19- supraclavicular and cervical lymphadenopathy bilaterally with mild sore throat and rhinorreah  1/20- lymphadenopathy improved.  Temp to 99.9.  Developed  periumbilical and right lower quadrant pain 1/21- abdominal pain worsened.  CT abdomen/pelvis with acute appendicitis for which I went to the OR for an appendectomy.
Nausea and emesis within 5 hours of administration, followed several hours later with several episodes of diarrhea. Low grade fever of 99-100.
Felt heady, immediately after injection; Sluggish; Lethargic; Bones hurt; Insomnia; Shallow breath; Needed to lay down/ Unable to drive; Body pain; Very sore at site of injection; Headache; Chills/Shivering; Muscle pain; Head rush, immediately after injection; Pain in arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Head rush, immediately after injection), HEAD DISCOMFORT (Felt heady, immediately after injection), SLUGGISHNESS (Sluggish), LETHARGY (Lethargic) and BONE PAIN (Bones hurt) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE/HYDROCHLOROTHIAZIDE), MAGNESIUM, VITAMIN D [VITAMIN D NOS], CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]) and ZINC for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced DIZZINESS (Head rush, immediately after injection) and VACCINATION SITE PAIN (Pain in arm of injection). On 26-Feb-2021, the patient experienced HEAD DISCOMFORT (Felt heady, immediately after injection), SLUGGISHNESS (Sluggish), LETHARGY (Lethargic), BONE PAIN (Bones hurt), INSOMNIA (Insomnia), HYPOPNOEA (Shallow breath), VACCINATION COMPLICATION (Needed to lay down/ Unable to drive), PAIN (Body pain), VACCINATION SITE REACTION (Very sore at site of injection), HEADACHE (Headache), CHILLS (Chills/Shivering) and MYALGIA (Muscle pain). At the time of the report, DIZZINESS (Head rush, immediately after injection), HEAD DISCOMFORT (Felt heady, immediately after injection), SLUGGISHNESS (Sluggish), LETHARGY (Lethargic), BONE PAIN (Bones hurt), INSOMNIA (Insomnia), HYPOPNOEA (Shallow breath), VACCINATION COMPLICATION (Needed to lay down/ Unable to drive), PAIN (Body pain), VACCINATION SITE REACTION (Very sore at site of injection), VACCINATION SITE PAIN (Pain in arm of injection), HEADACHE (Headache), CHILLS (Chills/Shivering) and MYALGIA (Muscle pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication details was reported.
Patient reports limited range of motion in shoulder of arm where sit of injection was located, loss of strength in entire arm, pain radiating throughout arm, small swollen nodule near injection site.
I experienced a breakthrough case of COVID-19 with nasal congestion, coughing, runny nose, body aches and a bad taste in my mouth.
pt states recv flu vax approx 615AM 15NOV96 & immed area became red & itchy;bandaid removed because states was possibly allergic to topic cortaid cream to inj site;DPH;
THE PATIENT HAS PAIN AT THE SITE, REDNESS AND SWELLING THAT HAS SPREAD TO AXILLA AND SIDE OF BODY.
an adverse reaction; severe chills; Severe shortness of breath; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Severe shortness of breath), PAIN IN EXTREMITY (arm soreness), ADVERSE REACTION (an adverse reaction) and CHILLS (severe chills) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced DYSPNOEA (Severe shortness of breath), PAIN IN EXTREMITY (arm soreness) and CHILLS (severe chills). On an unknown date, the patient experienced ADVERSE REACTION (an adverse reaction). On 02-Apr-2021, DYSPNOEA (Severe shortness of breath), PAIN IN EXTREMITY (arm soreness) and CHILLS (severe chills) had resolved. At the time of the report, ADVERSE REACTION (an adverse reaction) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient almost could not breathe, which subsided in about 30 but for a while he thought he might had to rush to the emergency room.  Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: No specific follow-up information recorded.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Body aches 24 hours after second dose - resolved 48 hours after onset.  fever of 102F 40 hours after second dose - down to 100F 45 hours after second dose - fever fluctuated between 99F and 102F until 64 hours after second dose. all symptoms resolved 72 hours after second dose.
Blood clot in large intestines which caused loss of blood supply and oxygen so it rotted which in turn rotted her small intestine and bowels which all had to be removed shut down her kidneys and liver
Hospitalized 04/23/2022-04/26/2022; COVID-19 positive 04/23/2022; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 4/23/2022 Discharge Date: 4/26/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: AKI (acute kidney injury) [N17.9] Lab test positive for detection of COVID-19 virus [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 47 y.o. female who presented to the emergency department with complaints of shortness of breath.  Patient has a past medical history of depression, type 2 diabetes, hypertension, hyperlipidemia, CKD stage 3, chronic pain, neuropathy, and chronic respiratory failure with home oxygen use due to LAM. Patient presented to the emergency department with complaints of shortness of breath, fever, chills and cough.  She had taken an at home COVID test which was positive on Thursday, 04/21/2022.  She states that on Sunday, she was exposed to COVID-19 during a family dinner.  She has been vaccinated and has received 1 COVID booster.  In the emergency department, patient was febrile, and her oxygen saturation dropped to 88% with any ambulation, however, at rest she did not require oxygen above her baseline of 2 liters/minute via nasal cannula.  Complete blood count was unremarkable.  BMP showed kidney disease, he procalcitonin was negative, lactic acid was negative, COVID-19 was positive.  Chest x-ray shows no acute cardiopulmonary disease.  Patient has been admitted for further evaluation management of COVID-19.   Patient was briefly turned up to 4 liters during her first night. She was weaned down to 3L 02 where she stayed the remainder of her stay. Her work of breathing was minimal and she was up in room without difficulty. Her AKI resolved. Patient felt medically stable to discharge home.  She is on 2L 02 at baseline and has oxygen at home. She was instructed to follow up with her PCP. She was discharged home with her mother in stable condition.
here with her granddaughter who is concerned about increasing SOB and weakness. brought in for evaluation of 4-5 days of gradual onset shortness of breath without chest pain.  She arrives using her daughter's oxygen, and she does not normally use oxygen.
approx 2mo p/vax pt was informed @ a blood donation ctr that tested positive for hepatitis B core antibody;pt was asymptomatic @ that time & remained asymptomatic;pt seen by MD who performed liver function test & hep panel MAR98 both neg;
Infection in throat, numbness and tingling in fingers, insomnia, loss of concentration, joints ache and muscle, cramps legs, mood angry, weight gain.
Fever, fussing, rash. x 5 days. Suspected rubella.
Day if injection Severe HA- that has not really let up 1 week later Facial numbness of injection side that spread to top of head, and down to chest and right arm- sensation of face being scaled on right side Day 2- Brain Fog, Generalized Weakness, Generalized pain Right ear remains numb Day 3 1/13- felt like my entire body received a tetanus vaccine Day 4 unchanged Day5- woke up in head to toe hives- was sent to ED Have been having intermittent rashes ( like dermatitis) pop up all over my body and random numbness typically on head/ neck Continue with headache on day 7
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2007, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster with complications. During 2015, the patient was treated by a physician for a persistent vesicular outbreak accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Sep2022 as dose number unknown (booster), single (Lot number: GJ2524) at the age of 52 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "depression" (unspecified if ongoing), notes: take medication for depression; "Known allergies: sulfa" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (29Mar2023) Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The treatment start date was 25Mar2023 and stop date reported as 29Mar2023 for the treatment of COVID-19.  Investigation result conclusion for lot number GJ2524: The investigation included reviewing the involved batch records, deviation investigation, an analysis of the complaint history for the reported lot and product type. The final scope was determined to be the associated lot(s) of the reported lot GJ2524. A complaint sample was not returned. No related quality issues were identified during the investigation. There is no impact on product quality, regulatory, validation and stability. RA (withheld) concludes that the reported defect is not representative of the quality of the batch and the batch remains acceptable. The RA process determined that no regulatory notification was required. The reported defect could not be confirmed. No root cause or CAPA were identified as the complaint was not confirmed.
Ache all over, joint pain fever nausea, extreme weakness/prostration , headache, felt like I might die, sore arm. Lasted about 18 hrs. 72 hrs later feel normal.
the muscle aches and pain; felt horrible; could not get out of bed; the muscle aches and pain; This is a follow up-spontaneous report from a contactable patient who reported that a patient of 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via unspecified route of administration on 21Apr2021 09:00 at single dose for COVID-19 immunization. Medical history reported was ongoing high cholesterol and it is controlled by medication. Concomitant medication reported was cholesterol for high cholesterol. Anatomical location was reported as left. History of all previous immunization with the Pfizer vaccine considered as suspect, Prior Vaccinations (within 4 weeks) and additional Vaccines Administered on Same Date of the Pfizer Suspect was reported as None. Caller received the first dose of the Pfizer-BioNTech COVID-19 Vaccine last 21Apr2021, at 9AM and mentioned by 9PM, she felt horrible. Caller mentioned she could not get out of bed, as if somebody beat her up. Caller took Tylenol for the pain. Two weeks later, the muscle aches and pain still persisted. Caller mentioned she will be receiving the next dose pretty soon, on 12May2021. She stated also that she was taking medications for high cholesterol. Offered to transfer to Safety, but Caller declined because she is busy. Consumer called regarding the Pfizer COVID 19 vaccine. Stated she got the first dose of the vaccine last week, when ask to provide the exact date and time she states she doesn't remember and does not have this information. Caller stated after the shot for three days she was in so much pain she can't get up; every morning that she wakes up she was in pain; all her muscles are hurting like someone hit her with a baseball bat and this in not normal. She was asking what if she get the second one and it gets worse. Regarding Muscle Pain patient stated she got the shot two weeks ago at about 0900AM and by 2100PM at that night it was horrible. It has continued to hurt; it is the same and sometimes worse especially when she wakes up in the morning. It was reported treatment was two weeks ago and caller does not have vaccination card with her to provide NDC, lot or expiration date. Caller mentioned the only thing she has high cholesterol, and it was controlled by medication. Caller attempts to provide a name of a product but was unsure of the spelling or pronunciation and stated it was cholesterol medication. Outcome of all the events was unknown.  No follow-up attempts are needed. No further information is expected.
Patient couldn't move her arm after the flu shot on Tuesday 10/26/2021 at 1:20pm.  Today is Thursday 10/28/2021 9:15am, her left arm is still hurting and can't move or pick up items with her left arm.  I informed the patient to visit her primary doctor to discuss further in regards to her symptoms.  My upper management will contact her tomorrow 10/29/2021 for follow up on her doctor visit today.
Hot, red, localized swelling left deltoid extending down to elbow.  Very sharp urticaria like border.
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age and gender. Medical history and drug reactions or allergies were not specified. On an unknown date, the patients might have been administered doses of (Oka/Merck) VARIVAX (dose, route and lot number were not reported) that had been improperly stored. No adverse effects were reported. Concomitant medications were not specified. This is one of several reports received from the same reporter. Additional information is not expected because there is no consent for follow up.
Pt seen in EC with reddened indurated painful area at site of tetanus injection (left glut) and fever (at time of examination 99.8 - per pt had taken acetaminophen earlier that day). Pt discharged from EC to home with rx's for Ibuprofen 800 mg, Diphenhydramine 25 mg, Cephalexin 500 mg, and Diflucan 150 mg.
Patient presented to the pharmacy with a swollen, red arm. it was  hot to the touch. I told the patient to take ibuprofen and put ice on the area. She said she also felt achey and had flu-like symptoms
fever of 100.1 for 8-9 hrs. day after shot , swollen lymph nodes in right arm pit, slight headache, fatigue, slight cough, 2 days
pt recv vax; became ill p/ 1 hr of adm; hives on chest & neck; felt "strange" in throat; SOB; epi & dph given;to er for further eval;
Fever of 103+F, weakness, difficulty walking, joint soreness...patient rested and was given tylenol doses of 975mg 2X
Physician, patient's son, and husband standing at patient's side throughout event. Within 5 minutes of receiving the 2nd COVID 19 vaccine, the patient began to report that she was feeling sharp shooting pains in her legs, arms and chest. The patient reported feeling anxious prior to the injection. Within 6-7 min, the patient began to experience difficult breathing at which time 911 was called. The patient was given 1 dose of Epi and one dose of Benadryl IM, which eased severity of the symptoms. The patient's vital signs remained within normal limits until time of transport to local hospital.
On 04/06/2021 a few hours after the vaccine a rash developed on my chest. that night. It was all over my arm, neck,  legs, and cheeks, a little low grade fever,  barely over 100. The next morning the rash was more prevalent, all over my body, a fever and a headache. I called the nurse's line. I discussed the symptoms over the phone. They just said if I had SOB to call and they called a few days later to check in. On the 2nd or 3rd day, I ended up taking Benadryl and it went away. And I took Advil for the headache.
ARM SWELLED UP AND WAS RED.  SORE.  COULDN'T SLEEP ON THAT ARM
Patient received I IM  injection of Johnson and Johnson vaccine. Patient went pale in the skin and felt lightheaded and unwell. Nurse supported patient and laid patient down on the cot next to table. Emergency response / Code Green on site vital signs stable patient recovering. Five minutes post incident patient walked to observation no immediate life threatening signs or symptoms. Patient refused additional medical support and transport.
arthritis in my hand is killing me/ arthritis in left hand has gotten worse; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (arthritis in my hand is killing me/ arthritis in left hand has gotten worse) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Arthritis (arthritis in her left hand) since an unknown date. Concomitant products included CORTISONE, ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) and PROBIOTIC 10 for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ARTHRITIS (arthritis in my hand is killing me/ arthritis in left hand has gotten worse). At the time of the report, ARTHRITIS (arthritis in my hand is killing me/ arthritis in left hand has gotten worse) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Wednesday 7/27 1830 received Jynneos vaccine in left deltoid. Approx 24 hours after on 7/28 2200 started having pruritis at itching site and observed swelling. Friday 7/29 2300 at night had vomiting, flu-like illness. Flu-like illness resolved Tuesday 8/2. Itching and discomfort at injection site has persisted as of 8/4.
This spontaneous report as received from a registered nurse concerning a patient of unknown age and gender. On 01-JUL-2014 the patient was vaccinated with the first dose of (Oka/Merck) VARIVAX (Lot #, dose and route not reported). On 01-JUL-2014 The patient received an improperly stored first dose of (Oka/Merck) VARIVAX. No adverse symptoms reported. This is one of several reports received from the same source. Additional information is not expected due to all follow ups requested to complete the case was received.
Information has been received from a pharmacist concerning a 27-year-old white female with a drug allergy to acetaminophen (+) hydrocodone bitartrate (VICODEN) who works as a hospital discharge planner who on 27-OCT-2005 (also reported as 18-OCT-2005) was vaccinated with a dose of measles virus vaccine vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot6492290149R). On approximately 03-NOV-2005, the patient was diagnosed with an active case of measles.  There was no product quality complaint.  Follow-up information received from a health care professional indicated that on 12-OCT-2005, the patient's rubeola IgG and mumps antibody IgG were negative.  On 27-Oct-2005, the patient developed measles.  On 03-NOV-2005, a rubella titer was positive for IgM antibodies, and an immune IgG rubeola IgM was positive.  The outcome was reported as recovered.  No additional information is expected.
pt recv vax 17OCT96 & 18OCT96 pt devel swelling & redness below the site of inj;however arm was not very sore;pt recovered;